Surprisingly, these relapses respond to the same chemotherapy if initial survival rate was greater than one year. Median survival is about 4 months for patients with recurrent disease. This case demonstrates the long-term therapeutic response of some patients and thus illustrates the importance of aggressive initial therapy. The Newsletter is distributed monthly by the Internal Medicine Residency Program. Its purpose is to communicate news important to resident physicians, faculty, and staff.
Contributions are welcome.
Deadline for news items to be included in the Newsletter is the 20 th of each month.